Optum guides providers through important upcoming formulary updates
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
November 7, 2019 - Teva and Celltrion announced the launch of Truxima (rituximab-abbs), a biosimilar to Genentech’s Rituxan® (rituximab).
Download PDF
Return to publications
